Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation

References

• Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File, TM Jr, Musher DM, Niederman MS, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 Suppl 2:S27-72; PMID:17278083; https://doi.org/10.1086/511159
   PubMed Web of Science ®Google Scholar
• Welte T, Köhnlein T. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network. Semin Respir Crit Care Med 2009; 30(2):127-35; https://doi.org/10.1055/s-0029-1202941
   PubMed Web of Science ®Google Scholar
• Fernández-Sabé N, Carratalà J, Rosón B, Dorca J, Verdaguer R, Manresa F, Gudiol F. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore) 2003; 82(3):159-69; https://doi.org/10.1097/01.md.0000076005.64510.87
   PubMed Web of Science ®Google Scholar
• ACIP Adult Immunization Work Group, Bridges CB, Woods L, Coyne-Beasley T; Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older-United States, 2013. MMWR Suppl 2013; 62(1):9-19
   Google Scholar
• Özlü T, Bülbül Y, Alataş F, Arseven O, Coşkun AŞ, Çilli A, Ekim N, Erdem H, Gürsel G, Hatipoǧlu ON, et al. Türk Toraks Derneǧi erişkinlerde toplumda gelişen pnömoni tanı ve tedavi uzlaşı raporu. Türk Toraks Dergisi 2009; 10:5-9 ( article in Turkish)
   Google Scholar
• Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, et al. Joint Taskforce of the european respiratory society and european society for clinical microbiology and infectious diseases. Guidelines for the management of adult lower respiratory tract infections–full version. Clin Microbiol Infect 2011; 17 Suppl 6:E1-59; https://doi.org/10.1111/j.1469-0691.2011.03672.x
   PubMed Web of Science ®Google Scholar
• Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2013; 1:CD000422
   PubMed Web of Science ®Google Scholar
• Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, Hanson CA, Mahoney LD, Shay DK, Thompson WW; Vaccine Safety Datalink. Effectiveness of pneumococcal polysaccharide vaccine in olderadults. N Engl J Med 2003; 348(18):1747-55; https://doi.org/10.1056/NEJMoa022678
   PubMed Web of Science ®Google Scholar
• Ortqvist A, Hedlund J, Burman LA, Elbel E, Höfer M, Leinonen M, Lindblad I, Sundelöf B, Kalin M. Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in the prevention of pneumonia in middle aged and elderly people. Lancet 1998; 351(9100):399-403; PMID:9482293; https://doi.org/10.1016/S0140-6736(97)07358-3
   PubMed Web of Science ®Google Scholar
• French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, Moore M, Antvelink D, Mulder D, Janoff EN, et al. 23-valent pneumococcal polysaccha- ride vaccine in HIV-1 infected Ugandan adults: double blind, randomized and placebo controlled trial. Lancet 2000; 355(9221):2106-11; PMID:10902624; https://doi.org/10.1016/S0140-6736(00)02377-1
   PubMed Web of Science ®Google Scholar
• Johnstone J, Eurich DT, Minhas JK, Marrie TJ, Majumdar SR. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia. Clin Infect Dis 2010; 51(1):15-22; https://doi.org/10.1086/653114
   PubMed Web of Science ®Google Scholar
• Vila-Córcoles A, Ochoa-Gondar O, Hospital I, Ansa X, Vilanova A, Rodríguez T, Llor C; EVAN Study Group. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Clin Infect Dis 2006; 43:860-8; PMID:16941367; https://doi.org/10.1086/507340
   PubMed Web of Science ®Google Scholar
• Maruyama T, Taguchi O, Niederman MS, Morser J, Kobayashi H, Kobayashi T, D'Alessandro-Gabazza C, Nakayama S, Nishikubo K, Noguchi T, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ 2010; 340:c1004; PMID:20211953; https://doi.org/10.1136/bmj.c1004
   PubMed Web of Science ®Google Scholar
• Domínguez A, Izquierdo C, Salleras L, Ruiz L, Sousa D, Bayas JM, Nebot M, Varona W, Celorrio JM, Carratalà J; Working Group for the Study of Prevention of CAP in the Elderly. Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly. Eur Respir J 2010; 36(3):608-14; https://doi.org/10.1183/09031936.00171309
   PubMed Web of Science ®Google Scholar
• Tsai YH, Hsieh MJ, Chang CJ, Wen YW, Hu HC, Chao YN, Huang YC, Yang CT, Huang CC. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old–Taiwan's PPV vaccination program. Vaccine 2015; 33(25):2897-902
   PubMed Web of Science ®Google Scholar
• Vila-Córcoles A, Ochoa-Gondar O, Llor C, Hospital I, Rodríguez T, Gómez A. Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects. Eur Respir J 2005; 26(6):1086-91; https://doi.org/10.1183/09031936.05.00030205
   PubMed Web of Science ®Google Scholar
• Fisman DN, Abrutyn E, Spaude KA, Kim A, Kirchner C, Daley J. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis 2006; 42(8):1093-101; https://doi.org/10.1086/501354
   PubMed Web of Science ®Google Scholar
• Mykietiuk A, Carratalà J, Domínguez A, Manzur A, Fernández-Sabé N, Dorca J, Tubau F, Manresa F, Gudiol F. Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 2006; 25(7):457-62; https://doi.org/10.1007/s10096-006-0161-8
   PubMed Web of Science ®Google Scholar
• Manzur A, Izquierdo C, Ruiz L, Sousa D, Bayas JM, Celorrio JM, Varona W, Nebot M, Salleras L, Domínguez A, et al. Working group for the study of prevention of community‐acquired pneumonia in the elderly. Influence of prior pneumococcal and influenza vaccination on outcomes of older adults with community-acquired pneumonia. J Am Geriatr Soc 2011; 59(9):1711-6; https://doi.org/10.1111/j.1532-5415.2011.03541.x
   PubMed Web of Science ®Google Scholar
• Johnstone J, Marrie TJ, Eurich DT, Majumdar SR. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch Intern Med 2007; 167(18):1938-43; https://doi.org/10.1001/archinte.167.18.1938
   PubMedGoogle Scholar
• Song JY, Lee JS, Wie SH, Kim HY, Lee J, Seo YB, Jeong HW, Kim SW, Lee SH, Park KH, et al. Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization. Clin Vaccine Immunol 2015; 22(2):229-34; https://doi.org/10.1128/CVI.00673-14
   PubMed Web of Science ®Google Scholar
• Ballinger MN, Standiford TJ. Postinfluenza bacterial pneumonia: host defenses gone awry. J Interferon Cytokine Res 2010; 30(9):643-52; https://doi.org/10.1089/jir.2010.0049
   PubMed Web of Science ®Google Scholar
• Song JY, Nahm MH, Cheong HJ, Kim WJ. Impact of preceding flu-like illness on the serotype distribution of pneumococcal pneumonia. PLoS One 2014; 9(4):e93477; https://doi.org/10.1371/journal.pone.0093477
   PubMed Web of Science ®Google Scholar
• Satman I, Akalin S, Cakir B, Altinel S; diaVAX Study Group. The effect of physicians' awareness on influenza and pneumococcal vaccination rates and correlates of vaccination in patients with diabetes in Turkey: an epidemiological Study “diaVAX.” Hum Vaccin Immunother 2013; 9(12):2618-26. Epub 2013 Jul 25; https://doi.org/10.4161/hv.25826
   PubMed Web of Science ®Google Scholar
• Özsu S, Uçar E, Arslan Y, Maden E, Bilgiç H. The Frequency of Influenza and Pneumococcal Vaccination in COPD. Eurasian J Pulmonol 2011; 13(1):21-5
   Google Scholar
• Akın L, Macabeo B, Caliskan Z, Altinel S, Satman I. Cost-effectiveness of increasing influenza coverage in adults with type 2 diabetes in Turkey. PLoS One 2016; 11(6):e0157657; PMID:27322384; https://doi.org/10.1371/journal.pone.0157657
   PubMed Web of Science ®Google Scholar
• Kaya A, Altinel N, Karakaya G, Cetinkaya F. Knowledge and attitudes among patients with asthma and parents and physicians towards influenza vaccination. Allergol Immunopathol (Madr) 2016; 45(3):240-3
   PubMed Web of Science ®Google Scholar
• Alici DE, Sayiner A, Unal S. Barriers to adult immunization and solutions: Personalized approaches. Hum Vaccin Immunother 2017; 13:213-5; PMID:27669411; https://doi.org/10.1080/21645515.2016.1234556
   PubMed Web of Science ®Google Scholar
• Boersma WG, Daniels JM, Löwenberg A, Boeve WJ, van de Jagt EJ. Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia. Respir Med 2006; 100(5):926-32; https://doi.org/10.1016/j.rmed.2005.06.018
   PubMed Web of Science ®Google Scholar
• Kauppinen MT, Lähde S, Syrjälä H. Roentgenographic findings of pneumonia caused by Chlamydia pneumoniae. A comparison with streptococcus pneumonia. Arch Intern Med 1996; 156(16):1851-6; https://doi.org/10.1001/archinte.1996.00440150107012
   PubMedGoogle Scholar
• Ono A, Okada F, Takata S, Hiramatsu K, Ando Y, Nakayama T, Maeda T, Mori H. A comparative study of thin-section CT findings between seasonal influenza virus pneumonia and Streptococcus pneumoniae pneumonia. Br J Radiol 2014; 87:20140051; PMID:24834476; https://doi.org/10.1259/bjr.20140051
   PubMed Web of Science ®Google Scholar
• Köksal I, Ozlü T, Bayraktar O, Yılmaz G, Bülbül Y, Oztuna F, Caylan R, Aydın K, Sucu, N; TUCAP Study Group. Etiological agents of community-acquired pneumonia in adult patients in Turkey; a multicentric, cross-sectional study. Tuberk Toraks 2010; 58(2):119-27; PMID:20865563
   PubMedGoogle Scholar
• Loubet P, Samih-Lenzi N, Galtier F, Vanhems P, Loulergue P, Duval X, Jouneau S, Postil D, Rogez S, Valette M, et al; FLUVAC Study Group. Factors associated with poor outcomes among adults hospitalized for influenza in France: a three-year prospective multicenter study. J Clin Virol 2016; 79:68-73
   PubMed Web of Science ®Google Scholar
• Castilla J, Guevara M, Martinez-Baz I, Ezpelata C, Delfrade J, Irrisari F, Moreno-Iribas C. Enhanced estimates of the influenza vaccination effect in preventing mortality: a prospective cohort study. Medicine (Baltimore) 2015; 94:e1240; PMID:26222861; https://doi.org/10.1097/MD.0000000000001240
   PubMed Web of Science ®Google Scholar
• Spaude KA, Abrutyn E, Kirchner C, Kim A, Daley J, Fisman DN. Influenza vaccination and risk of mortality among adults hospitalized with community-acquired pneumonia. Arch Intern Med 2007; 167:53-9; PMID:17210878; https://doi.org/10.1001/archinte.167.1.53
   PubMedGoogle Scholar
• Arriola CS, Anderson EJ, Baumbach J, Bennett N, Bohm S, Hill M, Lindegren ML, Lung K, Meek J, Mermel E, et al. Does influenza vaccination modify influenza severity ? Data on older adults hospitalized with influenza during the 2012–2013 season in the United States. J Infect Dis 2015; 212(8):1200-8; https://doi.org/10.1093/infdis/jiv200
   PubMed Web of Science ®Google Scholar
• Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009; 180(1):48-58; https://doi.org/10.1503/cmaj.080734
   PubMed Web of Science ®Google Scholar
• Jackson LA, Gurtman A, van Cleeff M, Jansen KU, Jayawardene D, Devlin C, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults. Vaccine 2013; 31(35):3577-84
   PubMed Web of Science ®Google Scholar
• Gündüz C, Tasbakan MS, Sayiner A, Cilli A, Kilinc O, Sakar Coskun A. Factors affecting treatment success in community-acquired pneumonia. Turk J Med Sci 2016; 46(5):1469-74; https://doi.org/10.3906/sag-1502-87
   PubMed Web of Science ®Google Scholar
• Marti C, Garin N, Grosgurin O, Poncet A, Combescure C, Carballo S, Perrier A. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Crit Care 2012; 16(4):R141; https://doi.org/10.1186/cc11447
   PubMed Web of Science ®Google Scholar
• Valencia M, Badia JR, Cavalcanti M, Ferrer M, Agustí C, Angrill J, García E, Mensa J, Niederman MS, Torres A. Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest 2007; 132(2):515-22; https://doi.org/10.1378/chest.07-0306
   PubMed Web of Science ®Google Scholar
• Zimmerman RK, Raymund M, Janosky JE, Nowalk MP, Fine MJ. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 2003; 21(13–14):1486-91; PMID:12615445; https://doi.org/10.1016/S0264-410X(02)00700-4
   PubMed Web of Science ®Google Scholar